Welcome to the e-CCO Library!

P624: Long-term effectiveness of anti-TNF therapy in pediatric-onset inflammatory bowel diseases: a population-based study
Year: 2022
Source: ECCO'22
Authors: Fumery, M.(1);Savoye, G.(2);Ley, D.(3);Dupont, C.(4);Bertrand, V.(5);Spyckerelle, C.(6);Guillon, N.(3);Desreumaux, P.(7);Gower-Rousseau, C.(8);Sarter, H.(9);Turck, D.(3);Leroyer, A.(9);
Created: Friday, 11 February 2022, 3:56 PM
P624: Vedolizumab can induce clinical remission in patients with chronic antibiotic-refractory pouchitis: A retrospective single-centre experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Verstockt1,2*, C. Claeys1, G. Van Assche1,2, A. D'Hoore3, A. Wolthuis3, S. Vermeire1,2, M. Ferrante1,2

Created: Thursday, 21 February 2019, 9:14 AM
P625 Kinetics and outcomes of transmural healing in patients with Crohn’s disease treated with anti-TNF therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Pastaud1, C. Hordonneau2, C. Lambert3, J. Vignette1, B. Pereira3, A. Buisson1

Created: Thursday, 30 January 2020, 10:12 AM
P625: A prospective study to assess the effectiveness of tacrolimus therapy in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Kishi*, F. Hirai, N. Takatsu, Y. Takada, Y. Yutaka, T. Takeda, K. Yao, T. Matsui, T. Ueki

Created: Thursday, 21 February 2019, 9:14 AM
P625: Characteristics of SARS-CoV-2 infection in IBD patients in the second and third wave compared with the first wave and with the data of general population
Year: 2021
Source: ECCO'21 Virtual
Authors: Guerra Marina, I.(1);Algaba, A.(1);Castro, S.(2);Jiménez, L.(1);Garza, D.(1);Aller, M.D.M.(1);Granja, A.(1);Guardiola, A.(1);Gil, M.(2);Ruiz, P.(2);Bermejo, F.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P625: Head-to-head comparison of three stool calprotectin tests for home use
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S-M. Haisma*1, A. Galaurchi2, S. Almahwzi2, J. Adekanmi Balogun2, A. Muller Kobold3, P. van Rheenen1

Created: Friday, 22 February 2019, 9:41 AM
P625: Predictors of pancreatitis among patients with inflammatory bowel disease (IBD) treated with vedolizumab (VDZ): Observation from a large global safety database
Year: 2022
Source: ECCO'22
Authors: Wernicke, J.(1);Verstak, T.(1);Zhang, T.(1);Spalding, W.(1);Lee, L.(1);Cheng, Y.(1);Ademi, A.(1);
Created: Friday, 11 February 2022, 3:56 PM
P625: Randomized controlled trial on the effect of megaboluses of intravenous corticosteroids added to oral corticosteroids in the treatment of moderately active ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Llaó, J.(1);Martín-Arranz, E.(2);Zabana, Y.(3);Navarro-Llavat, M.(4);Garcia-Planella, E.(5);Busquets, D.(6);Monfort, D.(7);Pineda, J.R.(8);Gutiérrez, A.(9);Villoria, A.(10);Menchén, L.(11);Bastida, G.(12);García-Alonso, F.J.(13);Rivero, M.(14);Chaparro, M.(15);Riestra, S.(16);Merino, O.(17);Rodríguez-Lago, I.(18);Barreiro-de-Acosta, M.(19);Domènech MoralPhD, E.(20)*;
Created: Friday, 14 July 2023, 11:05 AM
P625: Ustekinumab use in Crohn's disease: effectiveness of dose escalation
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Greenup A., Rosenfeld G., Bressler B.

Created: Wednesday, 20 February 2019, 10:36 AM
P626 Patients with IBD seek extra supportive care: insights from Israeli social media networks
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. SHARVIT1, I. Goren1,2, L. Godny1,2, K. Yadgar2, S. Elial Fatal2, R. Barkan2, D. Turner3, I. Dotan1,2, H. Yanai1,2

Created: Thursday, 30 January 2020, 10:12 AM
P626: Anti-TNF monotherapy is associated with an adverse clinical outcome in female Inflammatory Bowel Disease patients who stop Anti-TNF treatment during the third trimester of pregnancy.
Year: 2022
Source: ECCO'22
Authors: Lastiri, E.(1);Herrera-De Guise, C.(1);Casellas, F.(1);Mayorga, L.(1);Robles, V.(1);Cespedes, E.(1);Perez, Z.(1);Oller, E.(1);Borruel-Sainz, N.(1);
Created: Friday, 11 February 2022, 3:56 PM
P626: Development of a model of 3D imaging for the pre-operative planning of TaTME
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Sahnan1*, G. Pellino2, S.O. Adegbola1, P.J. Tozer1, P. Chandrasinghe3, D. Misovikc1, R. Hompes4, A.L. Hart5, J. Warusavitarne1, P.F. Lung6

Created: Thursday, 21 February 2019, 9:14 AM
P626: Higher discontinuation rates of anti-TNF therapy in elderly IBD patients compared with a younger age group: results from a prospective registry
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Smits*1, M. de Jong1, N. den Broeder1, M. Russel2, T. Römkens3, R. West4, J. Jansen5, F. Hoentjen1

Created: Friday, 22 February 2019, 9:41 AM
P626: Safety of recombinant zoster vaccine in patients with Inflammatory Bowel Disease: a single centre experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Todeschini, A.(1)*;Geccherle, A.(1);Signoretto, P.(1);Variola, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P626: SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: García Mateo, S.(1,2);Martínez-Domínguez, S.J.(1,2);Aso Gonzalvo, M.C.(1);Gargallo-Puyuelo, C.J.(1,2,3);Gallego Llera, B.(1,2);Arroyo Villarino, M.T.(1,2,3);Laredo de la Torre, V.(1,2);Nocito Colon, M.M.L.(4);Lario Quilez, L.(1);Refaie, E.(5);Latre Santos, M.(3);Gomollón García, F.(1,2,3,6);
Created: Wednesday, 2 June 2021, 4:12 PM
P626: Ustekinumab for the treatment of perianal fistulas in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Battat R.*1,2, Bessissow T.1, Strohl M.1, Kopylov U.3, Bitton A.1, Cohen A.2, Seidman E.1, Afif W.1

Created: Wednesday, 20 February 2019, 10:36 AM
P627 Acute severe ulcerative colitis in pregnancy: A retrospective cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Ollech1, I. Avni-Biron2, S. Dalal1, L. Glick1, S. Schafer1, J. Pekow1, R. Cohen1, D. Rubin1, A. Sakuraba1

Created: Thursday, 30 January 2020, 10:12 AM
P627: Change in urgency among ulcerative colitis patients: Analyses from the SPARC IBD
Year: 2021
Source: ECCO'21 Virtual
Authors: Lewis, J.(1);Shan, M.(2);Xhou, X.(2);Naegeli, A.(2);Hunter, T.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P627: HLA DQA1*05 was not associated to primary non-response or loss of response to first anti-TNF in real world Inflammatory Bowel Disease patients.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pascual Oliver, A.(1)*;Cuarán, C.(1);Casas-Deza, D.(1,2);García-López, S.(1,2);Corsino-Roche, P.(1,2);Sierra Moros, E.(1);Julián-Gomara, A.B.(1);Vicente-Lidón, R.(1);
Created: Friday, 14 July 2023, 11:05 AM